how to go from semaglutide to tirzepatide Inject Switching from Semaglutide to Tirzepatide

ADVANTAGE Why Intravenous and Infusions Therapies at GWCIM

Standard GLP-1 contraindications still apply Compounded semaglutide has safety risks and contraindications to consider: Semaglutide is not indicated for patients with a personal or family history of thyroid tumors, particularly medullary thyroid carcinoma (MTC) and neuroendocrine tumors such as MEN 2 (multiple endocrine neoplasia) type 2 syndrome

*Correspondence: Isabelle Boileau [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Future studies should identify the relevant CYP/UGT subtypes to assess the risk of drug-drug interactions and validate the safety threshold for quinone formation and detoxification capacity in humans

They instead use them as a preventative medication for those at a higher risk of developing clots